BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Diao L, Mei Q, Xu JM, Liu XC, Hu J, Jin J, Yao Q, Chen ML. Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice. World J Gastroenterol 2012; 18(10): 1059-1066 [PMID: 22416180 DOI: 10.3748/wjg.v18.i10.1059]
URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1059.htm
Number Citing Articles
1
Kyu‐Man Cho, Seon‐Young Park, Jin Ook Chung, Chung‐Hwan Jun, Tae‐Jong Kim, Dong‐Jun Son, Ban‐Suk Kim, Chang‐Hwan Park, Hyun‐Soo Kim, Sung‐Kyu Choi, Jong‐Sun Rew. Risk factors for small bowel bleeding in chronic nonsteroidal anti‐inflammatory drug usersJournal of Digestive Diseases 2015; 16(9): 499 doi: 10.1111/1751-2980.12269
2
D. A. Kashtanova, O. N. Tkacheva. The phenomenon of intestinal permeability and its association with cardiovascular disease. Current statusCardiovascular Therapy and Prevention 2020; 19(3): 2474 doi: 10.15829/1728-8800-2020-2474
3
Sarah M. R. Cosyns, Leander Huyghe, Robrecht Thoonen, Johannes‐Peter Stasch, Peter Brouckaert, Romain A. Lefebvre. Influence of cinaciguat on gastrointestinal motility in apo‐sGC miceNeurogastroenterology & Motility 2014; 26(11): 1573 doi: 10.1111/nmo.12424
4
Satoshi Kondo, Shota Mizuno, Tadahiro Hashita, Takahiro Iwao, Tamihide Matsunaga. Using human iPS cell-derived enterocytes as novel in vitro model for the evaluation of human intestinal mucosal damageInflammation Research 2018; 67(11-12): 975 doi: 10.1007/s00011-018-1193-0
5
Abdallah M. Gendy, Dalaal M. Abdallah, Hanan S. El-Abhar. The potential curative effect of rebamipide in hepatic ischemia/reperfusion injuryNaunyn-Schmiedeberg's Archives of Pharmacology 2017; 390(7): 691 doi: 10.1007/s00210-017-1370-7
6
Toru Imai, Katsuyuki Hazama, Yasuhiro Kosuge, Shinichiro Suzuki, Susumu Ootsuka. Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADERScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06611-y
7
Akanksha Mishra, Sairam Krishnamurthy. Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson’s Model in RatsNeurotoxicity Research 2019; 35(3): 542 doi: 10.1007/s12640-018-9983-2
8
Jan Martel, Shih-Hsin Chang, Yun-Fei Ko, Tsong-Long Hwang, John D. Young, David M. Ojcius. Gut barrier disruption and chronic diseaseTrends in Endocrinology & Metabolism 2022; 33(4): 247 doi: 10.1016/j.tem.2022.01.002
9
Dong Jun Oh, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, You-Jung Ha, Eun Ha Kang, Yun Jong Lee, Nayoung Kim, Ki-Jeoung Kim, Fei Liu. The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot studyThe Korean Journal of Internal Medicine 2022; 37(6): 1153 doi: 10.3904/kjim.2021.216
10
Dong Shin Kwak, Oh Young Lee, Kang Nyeong Lee, Dae Won Jun, Hang Lak Lee, Byung Chul Yoon, Ho Soon Choi. The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury ModelGut and Liver 2016; 10(3) doi: 10.5009/gnl15251
11
Ning Xu, Cuiping Zhang, Lili Jing, Shaojiao Mou, Xiaoling Cao, Zhenhai Yu. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injuryInternational Immunopharmacology 2021; 90: 107136 doi: 10.1016/j.intimp.2020.107136
12
A.T. Sougiannis, B.N. VanderVeen, R.T. Enos, K.T. Velazquez, J.E. Bader, M. Carson, I. Chatzistamou, M. Walla, M.M. Pena, J.L. Kubinak, M. Nagarkatti, J.A. Carson, E.A. Murphy. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiotaBrain, Behavior, and Immunity 2019; 80: 44 doi: 10.1016/j.bbi.2019.02.020
13
A. I. Martynov, A. A. Sheptulin, I. V. Mayev, A. N. Kazyulin, A. Ye. Karateev, A. V. Melekhov, L. K. Pal’gova, K. L. Raikhel’son. New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(2): 7 doi: 10.22416/1382-4376-2020-30-2-7-14
14
Jong M. Park, Ho J. Lee, Predrag Sikiric, Ki B. Hahm. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing CytoprotectionCurrent Pharmaceutical Design 2020; 26(25): 2971 doi: 10.2174/1381612826666200523180301
15
Matteo Fornai, Luca Antonioli, Rocchina Colucci, Carolina Pellegrini, Giulio Giustarini, Lara Testai, Alma Martelli, Antuela Matarangasi, Gianfranco Natale, Vincenzo Calderone, Marco Tuccori, Carmelo Scarpignato, Corrado Blandizzi. NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?Journal of Pharmacology and Experimental Therapeutics 2014; 348(1): 86 doi: 10.1124/jpet.113.207118
16
Gunuputi Sushma, Bhupesh Vaidya, Shikha Sharma, Geetanjali Devabattula, Mahendra Bishnoi, Kanthi Kiran Kondepudi, Shyam S. Sharma. Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouseNeuropharmacology 2023; 229: 109480 doi: 10.1016/j.neuropharm.2023.109480
17
Yijun Cheng, Yongxu Wei, Wenlei Yang, Yu Cai, Bin Chen, Guoyuan Yang, Hanbing Shang, Weiguo Zhao. Ghrelin Attenuates Intestinal Barrier Dysfunction Following Intracerebral Hemorrhage in MiceInternational Journal of Molecular Sciences 2016; 17(12): 2032 doi: 10.3390/ijms17122032
18
Damian Maseda, Emanuela Ricciotti. NSAID–Gut Microbiota InteractionsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01153
19
Somnath Mazumder, Samik Bindu, Subhashis Debsharma, Uday Bandyopadhyay. Induction of mitochondrial toxicity by non-steroidal anti-inflammatory drugs (NSAIDs): The ultimate trade-off governing the therapeutic merits and demerits of these wonder drugsBiochemical Pharmacology 2024; 228: 116283 doi: 10.1016/j.bcp.2024.116283
20
Yasuhito Funahashi, Masaki Yoshida, Tokunori Yamamoto, Tsuyoshi Majima, Shun Takai, Momokazu Gotoh. Intravesical Application of Rebamipide Suppresses Bladder Inflammation in a Rat Cystitis ModelJournal of Urology 2014; 191(4): 1147 doi: 10.1016/j.juro.2013.11.026
21
Zhuoran Han, Lunhua Ge, Siyi Wen, Jingfeng Sun. Dysfunction of the intestinal physical barrier in the intestinal inflammation of tongue sole, Cynoglossus semilaevis, induced by Shewanella algae infectionFish & Shellfish Immunology 2023; 139: 108900 doi: 10.1016/j.fsi.2023.108900
22
E. Pinto, K. Hrimpeng, G. Lopes, S. Vaz, M. J. Gonçalves, C. Cavaleiro, L. Salgueiro. Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte speciesEuropean Journal of Clinical Microbiology & Infectious Diseases 2013; 32(10): 1311 doi: 10.1007/s10096-013-1881-1
23
Takahiro Iwao, Tamihide Matsunaga. Intestinal cells differentiated from human induced pluripotent stem cells for use in drug development studiesTranslational and Regulatory Sciences 2019; 1(1): 24 doi: 10.33611/trs.1_24
24
Sherin Zakaria, Alaa El-Sisi. Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2Journal of Immunotoxicology 2016; 13(4): 453 doi: 10.3109/1547691X.2015.1128022
25
Cheng Yang, Mei-Hua Cui. NSAID-induced small intestinal mucosal injury: Mechanism, prevention and treatmentWorld Chinese Journal of Digestology 2019; 27(6): 347 doi: 10.11569/wcjd.v27.i6.347
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
26
Peter R. Kvietys, Ahmed Yaqinuddin, Wael Al Kattan. Gastrointestinal Mucosal Defense SystemColloquium Series on Integrated Systems Physiology: From Molecule to Function 2014; 6(5): 1 doi: 10.4199/C00119ED1V01Y201409ISP058
27
Dustin L. Cooper, Robert C. Wood, Jarrett E. Wyatt, Sam Harirforoosh. Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in ratsEuropean Journal of Pharmaceutical Sciences 2014; 53: 28 doi: 10.1016/j.ejps.2013.12.002